Capuano A - Search Results

1

Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report.

Maniscalco GT, Manzo V, Di Battista ME, Salvatore S, Moreggia O, Scavone C, Capuano A. Maniscalco GT, et al. Among authors: capuano a. Front Neurol. 2021 Aug 10;12:721502. doi: 10.3389/fneur.2021.721502. eCollection 2021. Front Neurol. 2021. PMID: 34447349 Free PMC article.

2

Atomoxetine in the treatment of attention deficit hyperactivity disorder and suicidal ideation.

Capuano A, Scavone C, Rafaniello C, Arcieri R, Rossi F, Panei P. Capuano A, et al. Expert Opin Drug Saf. 2014 Sep;13 Suppl 1:S69-78. doi: 10.1517/14740338.2014.941804. Expert Opin Drug Saf. 2014. PMID: 25171160

3

Disclosure of negative trial results. A call for action.

Capuano A, Coats AJ, Scavone C, Rossi F, Rosano GM. Capuano A, et al. Int J Cardiol. 2015 Nov 1;198:47-8. doi: 10.1016/j.ijcard.2015.06.157. Epub 2015 Jul 2. Int J Cardiol. 2015. PMID: 26151710 No abstract available.

4

Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF).

Capuano A, Scavone C, Vitale C, Sportiello L, Rossi F, Rosano GM, Coats AJ. Capuano A, et al. Int J Cardiol. 2015 Dec 1;200:15-9. doi: 10.1016/j.ijcard.2015.07.038. Int J Cardiol. 2015. PMID: 26404747 Review.

5

The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy.

Sportiello L, Rafaniello C, Scavone C, Vitale C, Rossi F, Capuano A. Sportiello L, et al. Among authors: capuano a. Int J Cardiol. 2016 Jan 1;202:731-5. doi: 10.1016/j.ijcard.2015.10.002. Epub 2015 Oct 9. Int J Cardiol. 2016. PMID: 26461922 Review.

6

Disclosing negative trial results - procedure.

Scavone C, Rafaniello C, Sportiello L, Berrino L, Capuano A. Scavone C, et al. Among authors: capuano a. Expert Rev Clin Pharmacol. 2016 Dec;9(12):1517-1519. doi: 10.1080/17512433.2016.1251838. Epub 2016 Nov 2. Expert Rev Clin Pharmacol. 2016. PMID: 27776436 No abstract available.

7

New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs).

Scavone C, Sportiello L, Rafaniello C, Mascolo A, Sessa M, Rossi F, Capuano A. Scavone C, et al. Among authors: capuano a. Expert Opin Drug Saf. 2016 Dec;15(sup2):85-100. doi: 10.1080/14740338.2016.1221396. Expert Opin Drug Saf. 2016. PMID: 27875916 Review.

8

Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs.

Sessa M, Rafaniello C, Sportiello L, Mascolo A, Scavone C, Maccariello A, Iannaccone T, Fabrazzo M, Berrino L, Rossi F, Capuano A. Sessa M, et al. Among authors: capuano a. Expert Opin Drug Saf. 2016 Dec;15(sup2):9-15. doi: 10.1080/14740338.2016.1221397. Expert Opin Drug Saf. 2016. PMID: 27875917

9

Scavone C, Sportiello L, Berrino L, Rossi F, Capuano A. Scavone C, et al. Among authors: capuano a. Pharmacol Res. 2017 May;119:265-271. doi: 10.1016/j.phrs.2017.02.006. Epub 2017 Feb 16. Pharmacol Res. 2017. PMID: 28214611 No abstract available.

10

Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions.

Sessa M, Sportiello L, Mascolo A, Scavone C, Gallipoli S, di Mauro G, Cimmaruta D, Rafaniello C, Capuano A. Sessa M, et al. Among authors: capuano a. Front Pharmacol. 2017 May 26;8:305. doi: 10.3389/fphar.2017.00305. eCollection 2017. Front Pharmacol. 2017. PMID: 28603499 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

590 results

Search Page